CONMED CorpCNMD

Market cap
$1.3B
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents---------2721292424
Accounts Receivable, after Allowance for Credit Loss, Current136139140129134148167182189177184191242238
Inventories168156143148167136141155165195232332318347
Prepaid expenses and other current assets1615172215191621181724293131
Total current assets357346372381407331357374397417460581616640
Property, plant and equipment, net139139139133125122116113119111109116121116
Deferred income taxes-------56710101111
Goodwill235257248256261398402400618618618815807805
Other intangible assets, net196191319316308420415413533502471682649618
Other assets-----------9496116
Total assets9361,0841,0911,0981,1131,3291,3581,3691,7751,7521,7662,2982,3002,306
Current portion of long-term debt--------1418127011
Accounts payable21242724354242535653587388102
Accrued compensation and benefits3134333632323443545060557065
Other current liabilities186447524930594665686699152110
Total current liabilities131123111116120114150161188190197297311278
Long-term debt--------755735672985973905
Deferred income taxes---------5869676174
Other long-term liabilities508745492427272647594320412186
Total liabilities3634774845175287487277071,0651,0439811,5521,4661,344
Preferred Stock, Value, Issued--------------
Common Stock, Value, Issued00000000000000
Paid-in capital322324326320325329334342379383397413447477
Retained earnings354378396406415407440465471457497413453560
Accumulated other comprehensive loss-26-28-18-40-54-59-49-56-59-64-54-58-50-59
Less: Treasury stock, at cost; 397,860 and 534,000 shares in 2024 and 2023, respectively776899105101979489816854231516
Total shareholders' equity573607606581585581631662710709785746834963
Total liabilities and shareholders' equity9361,0841,0911,0981,1131,3291,3581,3691,7751,7521,7662,2982,3002,306